57.108 Primary Bloodstream Infection (BSI)

The National Healthcare Safety Network (NHSN)

57.108_PrimaryBSI_BLANK

57.108 Primary Bloodstream Infection (BSI)

OMB: 0920-0666

Document [docx]
Download: docx | pdf


OMB No. 0920-0666

Exp. Date: xx-xx-xxx

www.cdc.gov/nhsn

Primary Bloodstream Infection (BSI)

Page 1 of 4

*required for saving **required for completion

Facility ID:

Event #:

*Patient ID:

Social Security #:

Secondary ID:

Medicare #:

Patient Name, Last:

First:

Middle:

*Gender: F M Other

*Date of Birth:

Ethnicity (Specify):

Race (Specify):

*Event Type: BSI

*Date of Event:

Post-procedure BSI: Yes No

Date of Procedure:

NHSN Procedure Code:

ICD-9-CM Procedure Code:

*MDRO Infection Surveillance:

Yes, this infection’s pathogen & location are in-plan for Infection Surveillance in the MDRO/CDI Module

No, this infection’s pathogen & location are not in-plan for Infection Surveillance in the MDRO/CDI Module

*Date Admitted to Facility:

*Location:

Risk Factors

*If ICU/Other locations, Central line: Yes No


*If Specialty Care Area,

Location of Device Insertion: _______________________

Permanent central line: Yes No


Temporary central line: Yes No

Date of Device Insertion: ___ /___ /________

*If NICU,


Central line, including umbilical catheter: Yes No


Birth weight (grams):


Event Details

*Specific Event: Laboratory-confirmed

*Specify Criteria Used:

Signs & Symptoms (check all that apply)

Underlying Conditions (check all that apply)

Any Patient

1 year old

Grade ≥ 3 acute GVHD within 7 days of blood culture collection date

Fever

Fever

Chronic GVHD in 3 months prior to blood culture collection date

Chills

Hypothermia

Leukemia or lymphoma

Hypotension

Apnea

Absolute neutrophil count (ANC) < 500 cells/mm3 within (+/-) 2 days of blood culture collection date


Bradycardia

Mucositis



Short gut syndrome






Laboratory (check one)



Recognized pathogen from one or more blood cultures



Common commensal from ≥ 2 blood cultures

**Died: Yes No

BSI Contributed to Death: Yes No

Discharge Date:

*Pathogens Identified: Yes No

*If Yes, specify on pages 2-3.

Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).

Public reporting burden of this collection of information is estimated to average 33 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN: PRA (0920-0666).

CDC 57.108 (Front) Rev. 5 v6.6

Primary Bloodstream Infection (BSI)

Page 2 of 4

Pathogen #

Gram-positive Organisms


_______


Staphylococcus coagulase-negative


VANC

S I R N

(specify): ________________________


_______


Enterococcus spp.( specify):


AMP

S I R N


CIPRO/LEVO/MOXI

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


GENTHL§

S R N


LNZ

S I R N

___________


STREPHL§

S R N



TETRA

S I R N



TIG

S NS N



VANC

S I R N



_______



Enterococcus faecium


AMP

S I R N


CIPRO/LEVO/MOXI

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


GENTHL§

S R N


LNZ

S I R N


QUIDAL

S I R N



STREPHL§

S R N



TETRA

S I R N



TIG

S NS N



VANC

S I R N



_______


Staphylococcus aureus


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


CLIND

S I R N


DAPTO

S NS N


DOXY/MINO

S I R N


ERYTH

S I R N


GENT

S I R N



LNZ

S R N



OX/CEFOX/METH

S I R N


QUIDAL

S I R N


RIF

S I R N


TETRA

S I R N


TIG

S NS N


TMZ

S I R N


VANC

S I R N

Pathogen #

Gram-negative Organisms


_______


Acinetobacter spp. (specify):


AMK

S I R N


AMPSUL

S I R N


AZT

S I R N


CEFEP

S I R N


CEFTAZ

S I R N


CIPRO/LEVO

S I R N


COL/PB

S I R N

____________


GENT

S I R N


IMI

S I R N



MERO/DORI

S I R N


PIP/PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TMZ

S I R N


TOBRA

S I R N



_______


Escherichia coli


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N



CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Enterobacter spp. (specify):


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N

____________


CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Klebsiella spp. (specify):


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N

____________


CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N



TIG

S I R N


TMZ

S I R N


TOBRA

S I R N


Primary Bloodstream Infection (BSI)

Page 3 of 4

Pathogen #

Gram-negative Organisms (continued)


_______


Serratia marcescens


AMK

S I R N


AMP

S I R N


AMPSUL/AMXCLV

S I R N


AZT

S I R N


CEFAZ

S I R N


CEFEP

S I R N


CEFOT/CEFTRX

S I R N



CEFTAZ

S I R N


CEFUR

S I R N


CEFOX/CETET

S I R N


CHLOR

S I R N


CIPRO/LEVO/MOXI

S I R N


COL/PB

S I R N



ERTA

S I R N


GENT

S I R N


IMI

S I R N


MERO/DORI

S I R N


PIPTAZ

S I R N


TETRA/DOXY/MINO

S I R N




TIG

S I R N


TMZ

S I R N


TOBRA

S I R N



_______


Pseudomonas aeruginosa


AMK

S I R N


AZT

S I R N


CEFEP

S I R N


CEFTAZ

S I R N


CIPRO/LEVO

S I R N


COL/PB

S I R N


GENT

S I R N



IMI

S I R N



MERO/DORI

S I R N


PIP/PIPTAZ

S I R N


TOBRA

S I R N


_______


Stenotrophomonas maltophilia


LEVO

S I R N


TETRA/MINO

S I R N


TICLAV

S I R N


TMZ

S I R N

Pathogen #

Fungal Organisms

_______

Candida spp. (specify): ____________


ANID

S I R N

CASPO

S NS N

FLUCO

S S-DD R N

FLUCY

S I R N

ITRA

S S-DD R N

MICA

S NS N

VORI

S S-DD R N

Pathogen #

Other Organisms

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N

_______

Organism 1 (specify)

____________


_______Drug 1

S I R N

_______ Drug 2

S I R N

______

Drug 3

S I R N

_______ Drug 4

S I R N

_______Drug 5

S I R N

______ Drug 6

S I R N

______ Drug 7

S I R N

______ Drug 8

S I R N

______ Drug 9

S I R N


Result Codes

S = Susceptible I = Intermediate R = Resistant NS = Non-susceptible S-DD = Susceptible-dose dependent N = Not tested

§ GENTHL and STREPHL results: S = Susceptible/Synergistic and R = Resistant/Not Synergistic


Drug Codes:





AMK = amikacin

CEFTRX = ceftriaxone

ERYTH = erythromycin

MICA = micafungin

STREPHL = streptomycin –

high level test

AMP = ampicillin

CEFUR= cefuroxime

FLUCO = fluconazole

MINO = minocycline

TETRA = tetracycline

AMPSUL = ampicillin/sulbactam

CETET= cefotetan

FLUCY = flucytosine

MOXI = moxifloxacin

TICLAV = ticarcillin/clavulanic acid

AMXCLV = amoxicillin/clavulanic acid

CHLOR= chloramphenicol

GENT = gentamicin

OX = oxacillin

TIG = tigecycline

ANID = anidulafungin

CIPRO = ciprofloxacin

GENTHL = gentamicin –high level test

PB = polymyxin B

TMZ = trimethoprim/sulfamethoxazole

AZT = aztreonam

CLIND = clindamycin

IMI = imipenem

PIP = piperacillin

TOBRA = tobramycin

CASPO = caspofungin

COL = colistin

ITRA = itraconazole

PIPTAZ = piperacillin/tazobactam

VANC = vancomycin

CEFAZ= cefazolin

DAPTO = daptomycin

LEVO = levofloxacin

QUIDAL = quinupristin/dalfopristin

VORI = voriconazole

CEFEP = cefepime

DORI = doripenem

LNZ = linezolid

RIF = rifampin


CEFOT = cefotaxime

DOXY = doxycycline

MERO = meropenem



CEFOX= cefoxitin

ERTA = ertapenem

METH = methicillin



CEFTAZ = ceftazidime





Primary Bloodstream Infection (BSI)

Page 4 of 4

Custom Fields

Label

Label

_________________________

____/____/_____

_______________________

____/____/_____

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________

_________________________

______________

_______________________

______________


Comments
















































File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorAmy Schneider
File Modified0000-00-00
File Created2021-01-31

© 2024 OMB.report | Privacy Policy